List of Excipients in API ertugliflozin and sitagliptin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ertugliflozin and sitagliptin
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Merck Sharp & Dohme LLC | STEGLUJAN | ertugliflozin and sitagliptin | 0006-5367 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2030-10-21 |
Merck Sharp & Dohme LLC | STEGLUJAN | ertugliflozin and sitagliptin | 0006-5367 | CARNAUBA WAX | 2030-10-21 |
Merck Sharp & Dohme LLC | STEGLUJAN | ertugliflozin and sitagliptin | 0006-5367 | CELLULOSE, MICROCRYSTALLINE | 2030-10-21 |
Merck Sharp & Dohme LLC | STEGLUJAN | ertugliflozin and sitagliptin | 0006-5367 | CROSCARMELLOSE SODIUM | 2030-10-21 |
Merck Sharp & Dohme LLC | STEGLUJAN | ertugliflozin and sitagliptin | 0006-5367 | FERRIC OXIDE RED | 2030-10-21 |
Merck Sharp & Dohme LLC | STEGLUJAN | ertugliflozin and sitagliptin | 0006-5367 | FERRIC OXIDE YELLOW | 2030-10-21 |
Merck Sharp & Dohme LLC | STEGLUJAN | ertugliflozin and sitagliptin | 0006-5367 | FERROSOFERRIC OXIDE | 2030-10-21 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ertugliflozin and sitagliptin
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
ertugliflozin and sitagliptin drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
ertugliflozin and sitagliptin drug variants containing CARNAUBA WAX
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing CARNAUBA WAX
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ertugliflozin and sitagliptin drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
ertugliflozin and sitagliptin drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
ertugliflozin and sitagliptin drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
ertugliflozin and sitagliptin drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
ertugliflozin and sitagliptin drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
ertugliflozin and sitagliptin drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
ertugliflozin and sitagliptin drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ertugliflozin and sitagliptin drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYL GALLATE
ertugliflozin and sitagliptin drug variants containing PROPYL GALLATE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing PROPYL GALLATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
ertugliflozin and sitagliptin drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ertugliflozin and sitagliptin drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
>Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.